ICON Public Limited
200.34
-17.65 (-8.10%)
At close: Jan 14, 2025, 3:59 PM
199.94
-0.20%
After-hours Jan 14, 2025, 07:59 PM EST

ICON Public Limited Revenue Breakdown

Quarter Dec 31, 2012Sep 30, 2012Dec 31, 2011
Central Laboratory Revenue 63.49M 23.98M 18.67M
Central Laboratory Revenue Growth +164.78% +28.44% n/a
Clinical Research Revenue 766.01M 261.52M 223.95M
Clinical Research Revenue Growth +192.90% +16.78% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012
Ireland Revenue 2.38B 1.98B 1.37B 273.55M 271.59M 1.07B 424.29M 410.57M 429.63M 360.38M 147.58M 132.79M
Ireland Revenue Growth +19.78% +45.29% +399.33% +0.72% -74.53% +151.29% +3.34% -4.44% +19.22% +144.19% +11.14% n/a
Other Countries Revenue 884.50M 3.57B 2.58B 925.56M 388.92M 254.72M 791.54M 178.91M 163.92M 164.49M n/a n/a
Other Countries Revenue Growth -75.26% +38.50% +178.86% +137.99% +52.69% -67.82% +342.43% +9.14% -0.35% n/a n/a n/a
Rest Of Europe Revenue 1.57B n/a n/a n/a 892.50M 379.88M n/a 763.82M 650.94M 605.82M n/a n/a
Rest Of Europe Revenue Growth n/a n/a n/a n/a +134.94% n/a n/a +17.34% +7.45% n/a n/a n/a
United States Revenue 3.28B n/a n/a n/a n/a 894.98M n/a n/a n/a n/a n/a n/a
United States Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 205.09M 194.46M 177.35M 195.56M 185.19M 187.81M 200.01M 226.75M 166.79M 189.95M 195.26M 202.72M 206.71M 109.88M 98.53M 87.88M 83.12M 83.50M 87.20M 86.18M 85.45M 83.20M 81.91M 83.12M 80.82M 80.94M 80.92M 82.09M 79.43M 80.83M 81.39M 83.53M 81.23M 80.17M 80.79M 83.48M 82.44M 81.32M 79.56M
Selling, General, and Administrative Revenue Growth +5.47% +9.65% -9.31% +5.60% -1.39% -6.10% -11.80% +35.95% -12.20% -2.72% -3.68% -1.93% +88.12% +11.52% +12.13% +5.73% -0.46% -4.24% +1.17% +0.86% +2.70% +1.58% -1.46% +2.85% -0.14% +0.03% -1.43% +3.34% -1.73% -0.68% -2.57% +2.83% +1.33% -0.77% -3.22% +1.26% +1.37% +2.22% n/a
Research and Development Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Create Price Alert on ICLR

Your price alert will notify you when the stock price is above 200.34.

Add to Watchlist